Pyoderma gangrenosum following reduction mammoplasty: a case report
Pyoderma gangrenosum (PG) is an inflammatory neutrophilic dermatosis of unknown etiology and is idiopathic in 25%- 50% cases. In approximately 50% of PG cases, an association with systemic diseases, such as Crohn's disease, monoclonal gammopathies, seropositive arthritis, collagenosis, Behcet...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Cirurgia Plástica
2018-12-01
|
Series: | Revista Brasileira de Cirurgia Plástica |
Subjects: | |
Online Access: | http://www.rbcp.org.br/details/2227/pyoderma-gangrenosum-following-reduction-mammoplasty--a-case-report |
_version_ | 1827601423588655104 |
---|---|
author | Carlos Jose Gaspar-Junior Carlos Jose Gaspar |
author_facet | Carlos Jose Gaspar-Junior Carlos Jose Gaspar |
author_sort | Carlos Jose Gaspar-Junior |
collection | DOAJ |
description | Pyoderma gangrenosum (PG) is an inflammatory neutrophilic dermatosis of unknown etiology and is idiopathic in 25%- 50% cases. In approximately 50% of PG cases, an association with systemic diseases, such as Crohn's disease, monoclonal gammopathies, seropositive arthritis, collagenosis, Behcet's disease, Wegener's granulomatosis, and myeloproliferative and infectious diseases (mainly hepatitis and AIDS), has been described. Clinically, PG presents four variants: ulcerated, bullous, vegetative, and pustular. The most frequent form is ulcerative, which begins as a papule or nodule and evolves rapidly into ulcerated and painful lesions. In approximately 25% of PG cases, the onset of new lesions can be triggered by traumas such as insect bites, intravenous injections, and biopsy, a phenomenon known as pathergy. Here, we present a case of extensive PG of the breasts following reductive mammoplasty surgery. It was a difficult case to diagnose and was initiated in the postoperative period of another service. Due to the breakdown of the doctor-patient relationship, the patient approached us for assistance. The patient showed an excellent response to corticotherapy (intra and perilesional corticotherapy with triamcinolone) during debridement and oral steroid (prednisone) therapy in the weaning phase. |
first_indexed | 2024-03-09T04:55:12Z |
format | Article |
id | doaj.art-8e90e52cbf1443ccb0762c40d6c43730 |
institution | Directory Open Access Journal |
issn | 1983-5175 2177-1235 |
language | English |
last_indexed | 2024-03-09T04:55:12Z |
publishDate | 2018-12-01 |
publisher | Sociedade Brasileira de Cirurgia Plástica |
record_format | Article |
series | Revista Brasileira de Cirurgia Plástica |
spelling | doaj.art-8e90e52cbf1443ccb0762c40d6c437302023-12-03T13:06:06ZengSociedade Brasileira de Cirurgia PlásticaRevista Brasileira de Cirurgia Plástica1983-51752177-12352018-12-01330459059410.5935/2177-1235.2018RBCP0183Pyoderma gangrenosum following reduction mammoplasty: a case reportCarlos Jose Gaspar-Junior0Carlos Jose Gaspar1Faculdade de Medicina de Jundiaí, Jundiaí, SP, BrazilClínica Particular, Dermatologia e Medicina Interna, Osasco, SP, BrazilPyoderma gangrenosum (PG) is an inflammatory neutrophilic dermatosis of unknown etiology and is idiopathic in 25%- 50% cases. In approximately 50% of PG cases, an association with systemic diseases, such as Crohn's disease, monoclonal gammopathies, seropositive arthritis, collagenosis, Behcet's disease, Wegener's granulomatosis, and myeloproliferative and infectious diseases (mainly hepatitis and AIDS), has been described. Clinically, PG presents four variants: ulcerated, bullous, vegetative, and pustular. The most frequent form is ulcerative, which begins as a papule or nodule and evolves rapidly into ulcerated and painful lesions. In approximately 25% of PG cases, the onset of new lesions can be triggered by traumas such as insect bites, intravenous injections, and biopsy, a phenomenon known as pathergy. Here, we present a case of extensive PG of the breasts following reductive mammoplasty surgery. It was a difficult case to diagnose and was initiated in the postoperative period of another service. Due to the breakdown of the doctor-patient relationship, the patient approached us for assistance. The patient showed an excellent response to corticotherapy (intra and perilesional corticotherapy with triamcinolone) during debridement and oral steroid (prednisone) therapy in the weaning phase.http://www.rbcp.org.br/details/2227/pyoderma-gangrenosum-following-reduction-mammoplasty--a-case-reportpyoderma gangrenosummammoplastyreconstructive surgical procedurespostoperative complicationsphysician-patient relationship |
spellingShingle | Carlos Jose Gaspar-Junior Carlos Jose Gaspar Pyoderma gangrenosum following reduction mammoplasty: a case report Revista Brasileira de Cirurgia Plástica pyoderma gangrenosum mammoplasty reconstructive surgical procedures postoperative complications physician-patient relationship |
title | Pyoderma gangrenosum following reduction
mammoplasty: a case report |
title_full | Pyoderma gangrenosum following reduction
mammoplasty: a case report |
title_fullStr | Pyoderma gangrenosum following reduction
mammoplasty: a case report |
title_full_unstemmed | Pyoderma gangrenosum following reduction
mammoplasty: a case report |
title_short | Pyoderma gangrenosum following reduction
mammoplasty: a case report |
title_sort | pyoderma gangrenosum following reduction mammoplasty a case report |
topic | pyoderma gangrenosum mammoplasty reconstructive surgical procedures postoperative complications physician-patient relationship |
url | http://www.rbcp.org.br/details/2227/pyoderma-gangrenosum-following-reduction-mammoplasty--a-case-report |
work_keys_str_mv | AT carlosjosegasparjunior pyodermagangrenosumfollowingreductionmammoplastyacasereport AT carlosjosegaspar pyodermagangrenosumfollowingreductionmammoplastyacasereport |